OriolaCHIX:ORIOLH 38 EV-to-EBITDA is 5.61 as of Jul. 09, 2026, which is 30% below its 10-year median of 8.00. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 38/100 and a GF Value™ of €0.99. The stock has 5 warning signs investors should review. Among 505 Healthcare Providers & Services companies, Oriola ranks better than 80.2% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oriola's enterprise value is €111 Mil.
Oriola's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €20 Mil. Therefore, Oriola's EV-to-EBITDA for today is 5.61.
The historical rank and industry rank for Oriola's EV-to-EBITDA or its related term are showing as below:
CHIX:ORIOLh'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.56 Med: 8 Max: 15.18
Current: 5.6
During the past 13 years, the highest EV-to-EBITDA of Oriola was 15.18. The lowest was 4.56. And the median was 8.00.
CHIX:ORIOLh's EV-to-EBITDA is ranked better than 80.2% of 505
companies
in the Healthcare Providers & Services industry
Industry Median: 10.95
vs CHIX:ORIOLh: 5.60
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-07-09), Oriola's stock price is €0.938.
Oriola's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.130. Therefore, Oriola's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Oriola (CHIX:ORIOLh) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oriola's share price for today is €0.938.
Oriola's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.130.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Oriola's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Oriola's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Oriola's EV-to-EBITDA falls into.
Oriola's current Enterprise Value is €111 Mil.
Oriola's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oriola (CHIX:ORIOLH) has a EV-to-EBITDA of 5.61 as of Jul. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oriola. This is 30% below median its historical median of 8.00. Over the past decade, Oriola's EV-to-EBITDA has ranged from 4.56 to 15.18. According to the industry distribution chart, Oriola ranks #100 out of 505 companies in the Healthcare Providers & Services industry, placing it in the top 19.8%.
Is Oriola's EV-to-EBITDA too high?
Oriola's current EV-to-EBITDA of 5.61 is 30% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 4.56 to a high of 15.18. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.95. Oriola's value of 5.61 is 48.8% below this industry median. Based on the distribution chart, Oriola ranks #100 out of 505 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Oriola has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Oriola's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #100 out of 505 companies for EV-to-EBITDA. This places Oriola in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.95. Oriola's value of 5.61 is 48.8% below this benchmark. Historically, Oriola's own EV-to-EBITDA has ranged from 4.56 to 15.18 over the past decade. While the company's 10-year median is 8.00 vs. the industry median of 10.95, Oriola has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.95, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oriola's current EV-to-EBITDA of 5.61 is 48.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oriola. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current EV-to-EBITDA is 5.61, which is 30% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Oriola (CHIX:ORIOLH) has a current EV-to-EBITDA of 5.61. The stock's GF Value™ is €0.99, compared to a current price of €0.94 — trading 5.3% below its estimated fair value. The current EV-to-EBITDA is 5.61, which is 30% below median its 10-year median of 8.00 and 48.8% below the Healthcare Providers & Services industry median of 10.95. Oriola's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current EV-to-EBITDA is 5.61 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be undervalued.
The current stock price of €0.94 is trading 5.3% below its estimated GF Value™ of €0.99.
Key valuation signals for CHIX:ORIOLH:
EV-to-EBITDA: 5.61 (30% below median its 10-year median of 8.00)
GF Value™: €0.99 vs. price of €0.94 (5.3% below fair value)
Industry Position: 48.8% below the Healthcare Providers & Services median (#100 of 505)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
38GF Score
Get the complete analysis for CHIX:ORIOLH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
